Lista de obras -

5q21 deletion is often heterogeneous in prostate cancer

scientific article published on 24 January 2019

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

artículo científico publicado en 2019

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

artículo científico publicado en 2019

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

artículo científico publicado en 2015

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

scientific article published in Scientific Reports

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

artículo científico publicado en 2013

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

artículo científico publicado en 2020

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

scientific article published on 19 November 2019

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

artículo científico publicado en 2014

Clinical significance of p53 alterations in surgically treated prostate cancers

artículo científico publicado en 2008

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

artículo científico publicado en 2015

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

scientific article published on 02 November 2015

Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer

artículo científico publicado en 2017

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

artículo científico publicado en 2016

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

artículo científico publicado en 2016

Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer

artículo científico publicado en 2010

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

scientific article published on 02 August 2019

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

scientific article published on 29 November 2019

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

artículo científico publicado en 2015

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

artículo científico publicado en 2018

Expression of the immune checkpoint receptor TIGIT in seminoma

scientific article published on 31 May 2019

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

artículo científico publicado en 2017

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2015

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer.

artículo científico publicado en 2015

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

artículo científico publicado en 2015

Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility.

artículo científico publicado en 2015

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.

artículo científico publicado en 2016

High B7-H3 expression is linked to increased risk of prostate cancer progression

artículo científico publicado en 2020

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

artículo científico publicado en 2018

High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

scientific article published on 18 April 2020

High RSF1 protein expression is an independent prognostic feature in prostate cancer

scientific article published on 05 November 2019

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

artículo científico publicado en 2017

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

artículo científico publicado en 2010

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

artículo científico publicado en 2013

High mitochondria content is associated with prostate cancer disease progression

artículo científico publicado en 2013

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

artículo científico publicado en 2013

High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

artículo científico publicado en 2012

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

artículo científico publicado en 2017

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

artículo científico publicado en 2015

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

artículo científico publicado en 2017

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

artículo científico publicado en 2019

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

artículo científico publicado en 2019

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

artículo científico publicado en 2018

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

artículo científico publicado en 2017

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer

artículo científico publicado en 2013

Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer

artículo científico publicado en 2012

Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

artículo científico publicado en 2018

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

scientific article published on 01 May 2019

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

artículo científico publicado en 2015

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

artículo científico publicado en 2020

Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse

artículo científico publicado en 2014

Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

artículo científico publicado en 2020

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer

artículo científico publicado en 2010

MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.

artículo científico publicado en 2013

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

artículo científico publicado en 2018

NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

artículo científico publicado en 2014

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

scientific article published on 24 December 2019

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

artículo científico publicado en 2015

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

artículo científico publicado en 2017

Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

artículo científico publicado en 2013

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

artículo científico publicado en 2015

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

artículo científico publicado en 2019

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

artículo científico publicado en 2020

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

artículo científico publicado en 2019

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

artículo científico publicado en 2015

SNW1 is a prognostic biomarker in prostate cancer

scientific article published on 01 May 2019

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

artículo científico publicado en 2013

Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

artículo científico publicado en 2014

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer

artículo científico publicado en 2014

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

artículo científico publicado en 2016

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

artículo científico publicado en 2019

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression.

artículo científico publicado en 2014

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

artículo científico publicado en 2015

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

artículo científico publicado en 2017

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

scientific article published on 25 September 2019

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

artículo científico publicado en 2017

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

artículo científico publicado en 2016

Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

artículo científico publicado en 2020

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

scientific article published on 25 April 2020

Upregulation of SPDEF is associated with poor prognosis in prostate cancer

artículo científico publicado en 2019

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

artículo científico publicado en 2020

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

scientific article published on 06 March 2020

VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

artículo científico publicado en 2015

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.

artículo científico publicado en 2016

Lista de obras de

5q21 deletion is often heterogeneous in prostate cancer

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

Clinical significance of p53 alterations in surgically treated prostate cancers

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

Expression of the immune checkpoint receptor TIGIT in seminoma

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer.

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility.

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.

High B7-H3 expression is linked to increased risk of prostate cancer progression

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

High RSF1 protein expression is an independent prognostic feature in prostate cancer

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

High mitochondria content is associated with prostate cancer disease progression

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer

Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer

Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse

Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer

MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

SNW1 is a prognostic biomarker in prostate cancer

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression.

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer